| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20117-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35029-10ug | |||
| Carrier-Free | NBP2-35029-1mg | |||
| Carrier-Free | NBP2-35029-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35241-1mg | |||
| Carrier-Free | NBP2-35241-100ug | |||
| Carrier-Free | NBP2-35241-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35255-10ug | |||
| Carrier-Free | NBP2-35255-1mg | |||
| Carrier-Free | NBP2-35255-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35057-1mg | |||
| Carrier-Free | NBP2-35057-100ug | |||
| Carrier-Free | NBP2-35057-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50289-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61126-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81031-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75188-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75198-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52687-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-09026-0.025mg | |||
![SDS-Page: Human IL-16 121 a.a Protein [NBP2-35029]](http://images.novusbio.com/fullsize/Human-IL-16-121-a.a-Protein-SDS-Page-NBP2-35029-img0001.jpg "SDS-Page: Human IL-16 121 a.a Protein [NBP2-35029]")
![SDS-Page: Rat IL-21 Protein [NBP2-35241]](http://images.novusbio.com/fullsize/Rat-IL-21-Protein-SDS-Page-NBP2-35241-img0001.jpg "SDS-Page: Rat IL-21 Protein [NBP2-35241]")
![SDS-Page: Rat IL-7 Protein [NBP2-35255]](http://images.novusbio.com/fullsize/Rat-IL-7-Protein-SDS-Page-NBP2-35255-img0001.jpg "SDS-Page: Rat IL-7 Protein [NBP2-35255]")
![SDS-Page: Human IL-21 Protein [NBP2-35057]](http://images.novusbio.com/fullsize/Human-IL-21-Protein-SDS-Page-NBP2-35057-img0001.jpg "SDS-Page: Human IL-21 Protein [NBP2-35057]")
![Western Blot: IL-4 Antibody (V17P1B4*B12) [Ovalbumine] - Azide and BSA Free [NBP2-61126] - Western blot image showing detection of recombinant IL4-4B1 (200 ng) using Anti-IL4-4B1 [V17P1B4*B12] at 1/2 dilution. Arrow indicates a correct band of 18 KDa.](http://images.novusbio.com/fullsize/IL-4-Antibody-V17P1B4-B12-Ovalbumine-Azide-and-BSA-Free-Western-Blot-NBP2-61126-img0001.jpg "Western Blot: IL-4 Antibody (V17P1B4*B12) [Ovalbumine] - Azide and BSA Free [NBP2-61126] - Western blot image showing detection of recombinant IL4-4B1 (200 ng) using Anti-IL4-4B1 [V17P1B4*B12] at 1/2 dilution. Arrow indicates a correct band of 18 KDa.")
![Immunocytochemistry/Immunofluorescence: CD3 epsilon Antibody (OKT-3 (muromonab)) [NBP2-81031] - Immunofluorescence staining of fixed Molt4 cells with CD3 epsilon Antibody (OKT-3 (muromonab)) [NBP2-81031]. Immunofluorescence analysis of paraformaldehyde fixed Molt4 cells on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of OKT-3 [NBP2-81031] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81031, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-OKT-3-muromonab-Immunocytochemistry-Immunofluorescence-NBP2-81031-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD3 epsilon Antibody (OKT-3 (muromonab)) [NBP2-81031] - Immunofluorescence staining of fixed Molt4 cells with CD3 epsilon Antibody (OKT-3 (muromonab)) [NBP2-81031]. Immunofluorescence analysis of paraformaldehyde fixed Molt4 cells on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of OKT-3 [NBP2-81031] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81031, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.")
![ELISA: CD27/TNFRSF7 Antibody (RM27-3E5) - Chimeric - Azide and BSA Free [NBP2-75198] - Binding curves of NBP2-75198 (red line) and isotype control (anti-Fluorescein antibody; blue line) to an ELISA plate coated with CD27-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10 mg/mL to 0.17 ng/ml of NBP2-75198 was used. CD70 (CD27-L) is the ligand for CD27. CD70 Fc-fusion protein was added to a 10mg/mL solution of NBP2-75198 starting at 10mg/mL, and then at 3-fold dilutions down to 0.17ng/mL (red line). A negative control assay using 4-1BB Fc-fusion protein was also performed (yellow line). For signal detection, a 1:4000 dilution of HRP-labelled anti-human IgG antibody was used.](http://images.novusbio.com/fullsize/nbp2-75198_rabbit-monoclonal-cd27-tnfrsf7-antibody-rm27-3e5-chimeric-7420252228563.png "ELISA: CD27/TNFRSF7 Antibody (RM27-3E5) - Chimeric - Azide and BSA Free [NBP2-75198] - Binding curves of NBP2-75198 (red line) and isotype control (anti-Fluorescein antibody; blue line) to an ELISA plate coated with CD27-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10 mg/mL to 0.17 ng/ml of NBP2-75198 was used. CD70 (CD27-L) is the ligand for CD27. CD70 Fc-fusion protein was added to a 10mg/mL solution of NBP2-75198 starting at 10mg/mL, and then at 3-fold dilutions down to 0.17ng/mL (red line). A negative control assay using 4-1BB Fc-fusion protein was also performed (yellow line). For signal detection, a 1:4000 dilution of HRP-labelled anti-human IgG antibody was used.")
![Flow Cytometry: OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) - Chimeric [NBP2-52687] - Human peripheral blood leukocytes were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with unimmunized rabbit IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of R4930 (NBP2-52687, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/OX40-Ligand-TNFSF4-Antibody-R4930-Oxelumab-Chimeric-Flow-Cytometry-NBP2-52687-img0001.jpg "Flow Cytometry: OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) - Chimeric [NBP2-52687] - Human peripheral blood leukocytes were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with unimmunized rabbit IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of R4930 (NBP2-52687, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.")